Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Respiratory syncytial virus
Recent news which mentions Respiratory syncytial virus
Merck says experimental RSV treatment protected infants in trial, paving way for potential approval
October 17, 2024
Tags
Merck & Co Inc
Companies
Pharmaceuticals
From
CNBC.com News
FDA approves GSK's RSV vaccine for high-risk adults ages 50 to 59, expanding shot's reach
June 07, 2024
Tags
Moderna Inc
Vaccinations
Biotechnology
From
CNBC.com News
Pfizer's RSV vaccine shows potential to protect high-risk adults ages 18-59, widening possible use
April 09, 2024
Tags
Biotechnology
Respiratory syncytial virus
US: News
From
CNBC.com News
RSV vaccine from GSK shows potential to protect adults 50 to 59
October 25, 2023
Tags
Business
GSK plc
Pharmaceuticals
From
CNBC.com News
CDC advisors recommend Pfizer maternal RSV vaccine to protect infants
September 22, 2023
Tags
Companies
Health care industry
Pharmaceuticals
From
CNBC.com News
FDA approves Pfizer maternal RSV vaccine for infants
August 21, 2023
Tags
Biotechnology
Immunizations
Health & Science
From
CNBC.com News
GSK sues Pfizer in U.S. court for patent infringement over RSV vaccine
August 02, 2023
Tags
Health & Science
Walgreens Boots Alliance Inc
Respiratory syncytial virus
From
CNBC.com News
GSK chief says RSV vaccine will start off slower than shingles shot – but will drive future sales
July 26, 2023
Tags
Business News
Biotechnology
Breaking news
From
CNBC.com News
CDC recommends RSV vaccines from Pfizer, GSK for adults 60 and older
June 29, 2023
Tags
Biotechnology
Health & Science
Immunizations
From
CNBC.com News
Pfizer, GSK RSV shots for older adults may prevent thousands of hospitalizations, CDC analysis says
June 22, 2023
Tags
Vaccinations
Biotechnology
Respiratory syncytial virus
From
CNBC.com News
CDC advisory panel backs use of GSK and Pfizer RSV vaccines in adults over 60
June 21, 2023
Tags
Respiratory syncytial virus
US: News
Social issues
From
CNBC.com News
GSK says RSV vaccine for older adults provides protection over two seasons
June 21, 2023
Tags
Vaccinations
Vaccine controversy
Biotechnology
From
CNBC.com News
Pfizer RSV vaccine for older adults is only slightly less effective after 18 months
June 21, 2023
Tags
Companies
Science
Business
From
CNBC.com News
FDA approves Pfizer RSV vaccine for older adults
May 31, 2023
Tags
U/S/ Economy
Business News
Pfizer Inc
From
CNBC.com News
Here’s what Pfizer and Moderna say is next for their Covid vaccines
May 22, 2023
Tags
Biotech and Pharmaceuticals
Pfizer Inc
Business News
From
CNBC.com News
FDA advisors recommend Pfizer’s RSV vaccine for infants but raise safety concerns
May 18, 2023
Tags
Pharmaceuticals
Health care industry
Science
From
CNBC.com News
Pfizer RSV vaccine for infants has 'generally favorable' safety data, FDA staff say
May 16, 2023
Tags
Science
Business
GSK plc
From
CNBC.com News
FDA approves GSK's RSV vaccine for older adults, world's first shot against virus
May 03, 2023
Tags
Breaking news
Business News
Pfizer Inc
From
CNBC.com News
FDA says Guillain-Barre syndrome is possible risk of Pfizer's RSV vaccine for older adults
February 24, 2023
Tags
Health & Science
US Top News and Analysis
Vaccinations
From
CNBC.com News
Moderna, Pfizer's new race: The RSV vaccine FDA approval process
January 18, 2023
Tags
Vaccinations
Moderna Inc
Pfizer Inc
From
CNBC.com News
A nutritionist shares the best snacks to bring on a plane to boost your immune system
December 26, 2022
Tickers
LIFE
Tags
Flu
Lifestyle
Travel safety
From
CNBC.com News
Why flu season is so bad this year
November 10, 2022
Tickers
LIFE
Tags
Biotech and Pharmaceuticals
U/S/ Economy
Business News
From
CNBC.com News
Pfizer RSV vaccine given to pregnant mothers is effective at protecting newborns, company's data shows
November 01, 2022
Tags
Epidemics
Business
Health care industry
From
CNBC.com News
Sanofi-AstraZeneca Say New Nirsevimab Data Reinforce Efficacy Against RSV
May 11, 2022
Tickers
AZN
AZNCF
SNY
Tags
Biotech
REspiratory syncytial virus
Market News
From
Benzinga
Pfizer's RSV Vaccine Candidate Receives FDA Breakthrough Therapy Tag For Prevention of RSV In Older Adults
March 24, 2022
Tickers
PFE
Tags
Benzinga
News
General
From
Benzinga
Johnson & Johnson Posts Additional RSV Vaccine Data
December 07, 2021
Tickers
JNJ
Tags
Briefs
Benzinga
News
From
Benzinga
J&J's RSV Vaccine Candidate Shows 80% Efficacy In Older Adults
October 04, 2021
Tickers
JNJ
Tags
Benzinga
News
General
From
Benzinga
Pfizer Starts Late-Stage Trial For RSV Vaccine Candidate In Older Patients
September 02, 2021
Tickers
PFE
Tags
Briefs
PFE
General
From
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today